Zealand Pharma A/s Stock
Zealand Pharma A/s Stock
Zealand Pharma A/s gained 0.840% compared to yesterday.
Criterium "Worthwhile Investment for the next years" is seen as the biggest plus for Zealand Pharma A/s stock. Negative votes have not been in the majority for any criteria for this stock
Pros and Cons of Zealand Pharma A/s in the next few years
Pros
?
W********* I********* f** t** n*** y****
?
S********** s********
?
G***** c******* t* c**********
Cons
?
B****
?
C******** o* t** e**********
?
M***** P*******
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Zealand Pharma A/s vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Zealand Pharma A/s | 0.840% | 5.814% | -26.288% | -50.146% | -41.404% | 22.757% | - |
| Saniona AB | 0.420% | 1.826% | -37.365% | 144.932% | -24.400% | 139.669% | -33.486% |
| Ocuphire Pharma Inc. | -2.570% | -6.864% | 29.228% | 274.762% | 133.948% | 9.458% | - |
| Immunic Inc. | 0.590% | -15.177% | 21.498% | -5.094% | 133.953% | -35.201% | -92.379% |
News
Why 2026 Could Be Another Breakout Year for Rocket Lab
The momentum has shown little sign of slowing for Rocket Lab (NASDAQ: RKLB). Shares of the aerospace and defense company have gone from strength to strength, rising roughly 1,775% over the past
New APAC Partnership with Matter Brings Market Logic Software's Always-On Insights Solutions to Local Brand and Experience Leaders
BERLIN, DE / ACCESS Newswire / December 16, 2025 / Market Logic Software, the market-leading SaaS provider of insight management solutions, has announced a partnership with Matter, a New
Why Rocket Lab Stock Keeps Going Up
Rocket Lab (NASDAQ: RKLB) stock rocketed to a 10th straight day of gains Friday, surging 5.7% through 11:15 a.m. ET after announcing the New Zealand-based space company announced yet another big
